Market Overview

31 Healthcare Stocks Moving In Friday's Pre-Market Session

Share:

Gainers

  • Flexion Therapeutics, Inc. (NASDAQ: FLXN) stock surged 24.6% to $23.90 during Friday's pre-market session. The market value of their outstanding shares is at $655.0 million. The most recent rating by Raymond James, on December 27, is at Strong Buy, with a price target of $28.00.
  • Rite Aid, Inc. (NYSE: RAD) stock moved upwards by 15.1% to $22.10. The market value of their outstanding shares is at $497.1 million.
  • Verona Pharma, Inc. (NASDAQ: VRNA) stock increased by 14.7% to $7.55. The market cap stands at $61.8 million.
  • Genfit, Inc. (NASDAQ: GNFT) shares moved upwards by 11.1% to $21.07. The market cap seems to be at $560.7 million.
  • Assertio Therapeutics, Inc. (NASDAQ: ASRT) shares moved upwards by 9.6% to $1.48. The market cap seems to be at $61.3 million.
  • Onconova Therapeutics, Inc. (NASDAQ: ONTX) stock rose 8.4% to $0.34. The market cap seems to be at $4.3 million.
  • Mereo BioPharma Group, Inc. (NASDAQ: MREO) shares increased by 7.0% to $2.30. The market value of their outstanding shares is at $54.9 million.
  • Cassava Sciences, Inc. (NASDAQ: SAVA) stock rose 6.7% to $4.30. The market cap seems to be at $20.6 million.
  • DBV Technologies, Inc. (NASDAQ: DBVT) stock increased by 6.4% to $11.11. The market value of their outstanding shares is at $676.0 million. The most recent rating by Citigroup, on December 16, is at Buy, with a price target of $14.00.
  • Microbot Medical, Inc. (NASDAQ: MBOT) shares surged 6.0% to $14.84. The market cap seems to be at $21.2 million. The most recent rating by H.C. Wainwright, on December 24, is at Buy, with a price target of $12.00.
  • Bionano Genomics, Inc. (NASDAQ: BNGO) shares surged 3.9% to $1.08. The market value of their outstanding shares is at $20.9 million.
  • Advaxis, Inc. (NASDAQ: ADXS) stock increased by 3.6% to $0.72. The market cap seems to be at $25.8 million.
  • Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) shares rose 3.4% to $3.62. The market value of their outstanding shares is at $1.0 billion. The most recent rating by Cantor Fitzgerald, on December 26, is at Neutral, with a price target of $4.00.
  • TG Therapeutics, Inc. (NASDAQ: TGTX) shares increased by 3.4% to $11.51. The market value of their outstanding shares is at $659.9 million. The most recent rating by Cantor Fitzgerald, on November 14, is at Overweight, with a price target of $19.00.
  • PAVmed, Inc. (NASDAQ: PAVM) stock increased by 3.4% to $1.22. The market cap stands at $33.1 million.
  • Spring Bank, Inc. (NASDAQ: SBPH) shares moved upwards by 3.3% to $1.24. The market cap seems to be at $48.8 million. The most recent rating by PiperJaffray, on December 27, is at Neutral, with a price target of $1.70.
  • Guardion Health Sciences, Inc. (NASDAQ: GHSI) stock rose 3.2% to $0.21. The market cap stands at $20.3 million.
  • Oncolytics Biotech, Inc. (NASDAQ: ONCY) shares surged 2.8% to $2.90. The market cap stands at $30.6 million.
  • Citius Pharmaceuticals, Inc. (NASDAQ: CTXR) shares moved upwards by 2.6% to $1.18. The market cap seems to be at $13.2 million.
  • Qiagen, Inc. (NYSE: QGEN) shares rose 2.4% to $33.71. The market cap stands at $9.6 billion. The most recent rating by Bank of America, on December 26, is at Underperform, with a price target of $28.00.
  • NewLink Genetics, Inc. (NASDAQ: NLNK) shares increased by 2.2% to $3.20. The market value of their outstanding shares is at $56.7 million.
  • Outlook Therapeutics, Inc. (NASDAQ: OTLK) stock surged 2.0% to $0.56. The market cap seems to be at $29.7 million.
  • AstraZeneca, Inc. (NYSE: AZN) shares increased by 1.8% to $50.77. The market value of their outstanding shares is at $126.9 billion. The most recent rating by Cowen & Co., on December 02, is at Outperform, with a price target of $55.00.
  • GlaxoSmithKline, Inc. (NYSE: GSK) shares increased by 1.8% to $47.76. The market value of their outstanding shares is at $112.9 billion. According to the most recent rating by UBS, on November 21, the current rating is at Buy.
  • Smith & Nephew, Inc. (NYSE: SNN) stock increased by 1.3% to $48.66. The market cap stands at $19.5 billion. According to the most recent rating by Bernstein, on November 12, the current rating is at Outperform.

 

Losers

  • Acasti Pharma, Inc. (NASDAQ: ACST) shares plummeted 5.2% to $2.55 during Friday's pre-market session. The market cap stands at $158.4 million. The most recent rating by B. Riley FBR, on November 18, is at Buy, with a price target of $8.00.
  • Helius Medical Tech, Inc. (NASDAQ: HSDT) stock plummeted 4.8% to $1.00. The market value of their outstanding shares is at $15.6 million.
  • Acorda Therapeutics, Inc. (NASDAQ: ACOR) shares declined 4.7% to $2.62. The market value of their outstanding shares is at $76.8 million. According to the most recent rating by JP Morgan, on October 24, the current rating is at Underweight.
  • Liquidia Technologies, Inc. (NASDAQ: LQDA) stock fell 3.0% to $4.90. The market cap stands at $81.7 million. The most recent rating by Wedbush, on December 26, is at Outperform, with a price target of $37.00.
  • Diffusion Pharmaceuticals, Inc. (NASDAQ: DFFN) stock declined 1.8% to $0.40. The market value of their outstanding shares is at $3.9 million. The most recent rating by H.C. Wainwright, on December 18, is at Buy, with a price target of $3.50.
  • Aurora Cannabis, Inc. (NYSE: ACB) shares plummeted 1.5% to $1.98. The market value of their outstanding shares is at $2.6 billion. The most recent rating by Piper Jaffray, on October 22, is at Neutral, with a price target of $4.00.
 

Related Articles (ACOR + ACB)

View Comments and Join the Discussion!

Posted-In: Healthcare Stocks Pre-Market MoversNews Movers & Shakers Pre-Market Outlook Markets Movers Trading Ideas General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com